The collaboration brings Kent's tissue assessment devices, SnapshotNIR and SnapshotGLO, together with Marathon Medical's over two decades of expertise supporting the VA.
This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community.”— Pierre Lemire, CEO
CALGARY, AB – ALBERTA, CANADA, August 26, 2026 /EINPresswire.com/ — Kent Imaging Inc., a frontrunner in near-infrared tissue oxygenation and bacterial autofluorescence imaging, has unveiled a new alliance with Marathon Medical Corporation, a Service-Disabled Veteran-Owned Small Business (SDVOSB) focused on federal healthcare distribution. Together, the two entities will widen the availability of Kent Imaging's state-of-the-art wound imaging tools across U.S. Department of Veterans Affairs (VA) medical sites, enabling clinicians to detect patients at risk for wound complications sooner and foster improved outcomes for America's Veterans.
The alliance merges Kent Imaging's bedside tissue evaluation devices, SnapshotNIR and SnapshotGLO, along with any upcoming product innovations, with Marathon Medical's more than 20 years of know-how serving the VA, Department of Defense, and other federal health agencies. Established by Vietnam Veteran John St. Leger, Marathon Medical has constructed its operations around supporting the federal healthcare system that cares for those who have served the nation.
Chronic wounds and lower limb issues continue to pose a major health challenge within the Veteran population, especially among individuals managing diabetes and peripheral arterial disease (PAD). By delivering objective data on tissue oxygenation and bacterial load at the point of care, Kent Imaging’s solutions aid earlier clinical choices to enhance healing results and decrease preventable amputations.
“This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community,” said Pierre Lemire, CEO of Kent Imaging. “We are proud to work with Marathon Medical to bring innovative imaging solutions to the clinicians who care for patients in need.”
“Echoing that commitment, this partnership gives us an opportunity to put that mission into action by expanding access to advanced wound imaging where it can make a meaningful difference in patient care,” adds Chris Tiemann, Vice President of Sales, Kent Imaging.
As a Service-Disabled Veteran-Owned Small Business, Marathon Medical is committed to delivering superior medical products and professional, individualized service throughout the federal healthcare system. The firm works closely with VA hospitals, military treatment centers, and other government bodies to guarantee that providers obtain timely access to cutting-edge medical technologies.
"At Marathon Medical, our mission has always been to serve those who served. We are pleased to have Kent Imaging’s Snapshot suite as part of that mission," said Jon Landis, Chief Commercialization Officer, Marathon Medical.
The partnership reinforces both organizations' dedication to progressing Veteran Healthcare through innovation while strengthening collaboration between medical technology firms and veteran-owned businesses committed to serving the federal healthcare community.
About Kent Imaging
Based in Calgary, Alberta, Canada, Kent Imaging is a foremost innovator in advanced imaging technology. The company designs, manufactures, and markets medical devices that support real-time decision-making in wound care, vascular, and surgical specialties. Through patented technologies, Kent continues to deliver groundbreaking solutions that support healthcare systems around the world.
The Snapshot product suite now includes two powerful imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device initially cleared by the FDA and Health Canada in 2017 and CE-marked in 2025; and SnapshotGLO, a bacterial autofluorescence imaging device that received FDA 510(k) clearance in 2025. SnapshotNIR is supported by clinical evidence demonstrating its role in enhancing clinical decision-making, while SnapshotGLO provides real-time insight into wound bioburden presence and distribution. Together, the Snapshot product family strengthens clinicians' ability to detect, direct, and protect—promoting treatment consistency, supporting improved workflow, and contributing to better patient care worldwide.
SnapshotGLO® is a registered trademark of Kent Imaging Inc.
SnapshotNIR® is a registered trademark of Kent Imaging Inc.
About Marathon Medical
Founded in 2002, Marathon Medical Corporation is a Service-Disabled Veteran-Owned Small Business (SDVOSB) headquartered in Aurora, Colorado. The company specializes in supplying medical products to the U.S. Department of Veterans Affairs, Department of Defense, and other federal healthcare agencies, with a mission to provide excellence to the healthcare supply chain through professional, personal service.
Leah Pavlick
Kent Imaging Inc.
leah@kentimaging.com
Visit us on social media:
LinkedIn
